Literature DB >> 14971656

Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest.

Jian Xu1, Francis C R Manning, Travis J O'Brien, Susan Ceryak, Steven R Patierno.   

Abstract

Chromium(VI) (Cr(VI)) can suppress both DNA replication and transcription as a result of chromium (Cr)-induced DNA damage. While progress has been made in the characterization of Cr-induced DNA polymerase arresting lesions, very little information is available on the inhibition of transcription by this metal. The aim of the present study was to identify the molecular mechanisms involved in the reduction of RNA synthesis by Cr. Following treatment with a moderately cytotoxic dose (approximately LC50) of Cr(VI) (150 microM for 2 h), total RNA synthesis was initially suppressed in CHO cells and recovered to control levels within 72 h post-treatment. In vitro nuclear run-on transcription assays of nuclei isolated from Cr(VI)-treated cells showed a similar amount of RNA synthesis suppression as observed in intact cells. Qualitative analysis of nascent transcripts revealed a general, concentration-dependent reduction in size suggesting that transcriptional elongation was inhibited following Cr-treatment. Transcriptional initiation in these nuclei was also reduced. To better determine whether transcriptional suppression was related to Cr-induced DNA damage we examined the transcriptional activity of T7 RNA polymerase on Cr(III)-treated plasmid DNA. Treatment of pGEM3Z-TS DNA with Cr(III) resulted in transcriptional arrest which occurred primarily at GC-rich and palindromic regions. However, in contrast to the cellular data, transcriptional initiation was unaffected in the in vitro transcription arrest assays. Taken together, these results suggest that the suppression of RNA synthesis by Cr is related to chromium-induced template DNA damage which prevents elongation leading to premature RNA polymerase arrest.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971656     DOI: 10.1023/b:mcbi.0000007271.53241.ae

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  45 in total

1.  Myelomas and lymphomas expressing the Ig gamma 2a H chain gene have similar transcription termination regions.

Authors:  J A Flaspohler; C Milcarek
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

2.  DNA polymerase arrest by adducted trivalent chromium.

Authors:  L C Bridgewater; F C Manning; E S Woo; S R Patierno
Journal:  Mol Carcinog       Date:  1994-03       Impact factor: 4.784

3.  Preferential formation and repair of chromium-induced DNA adducts and DNA--protein crosslinks in nuclear matrix DNA.

Authors:  J Xu; F C Manning; S R Patierno
Journal:  Carcinogenesis       Date:  1994-07       Impact factor: 4.944

4.  Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism.

Authors:  J A Shumilla; K E Wetterhahn; A Barchowsky
Journal:  Arch Biochem Biophys       Date:  1998-01-15       Impact factor: 4.013

5.  Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells.

Authors:  D E Pritchard; J Singh; D L Carlisle; S R Patierno
Journal:  Carcinogenesis       Date:  2000-11       Impact factor: 4.944

6.  Molecular basis of hexavalent chromium carcinogenicity: effect on gene expression.

Authors:  K E Wetterhahn; J W Hamilton
Journal:  Sci Total Environ       Date:  1989-10-01       Impact factor: 7.963

7.  Transcriptional inhibition by carcinogenic chromate: relationship to DNA damage.

Authors:  F C Manning; J Xu; S R Patierno
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

8.  Effects of DNA lesions on transcription elongation by T7 RNA polymerase.

Authors:  Y H Chen; D F Bogenhagen
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

9.  Mode of enhancement in ribonucleic acid synthesis directed by chromium (III)-bound deoxyribonucleic acid.

Authors:  S Okada; M Taniyama; H Ohba
Journal:  J Inorg Biochem       Date:  1982-08       Impact factor: 4.155

10.  Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein. Requirement of ATM for both apoptosis and recovery from terminal growth arrest.

Authors:  Linan Ha; Susan Ceryak; Steven R Patierno
Journal:  J Biol Chem       Date:  2003-03-10       Impact factor: 5.157

View more
  6 in total

Review 1.  Chromium exposure disrupts chromatin architecture upsetting the mechanisms that regulate transcription.

Authors:  Hesbon A Zablon; Andrew VonHandorf; Alvaro Puga
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-01

2.  Chromium disrupts chromatin organization and CTCF access to its cognate sites in promoters of differentially expressed genes.

Authors:  Andrew VonHandorf; Francisco Javier Sánchez-Martín; Jacek Biesiada; Hongxia Zhang; Xiang Zhang; Mario Medvedovic; Alvaro Puga
Journal:  Epigenetics       Date:  2018-05-03       Impact factor: 4.528

3.  Long-term exposure to hexavalent chromium inhibits expression of tumor suppressor genes in cultured cells and in mice.

Authors:  Yunxia Fan; Jerald L Ovesen; Alvaro Puga
Journal:  J Trace Elem Med Biol       Date:  2012-05-19       Impact factor: 3.849

4.  Nucleotide excision repair functions in the removal of chromium-induced DNA damage in mammalian cells.

Authors:  Travis J O'Brien; Bradford R Brooks; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

5.  Differential impact of ionic and coordinate covalent chromium (Cr)-DNA binding on DNA replication.

Authors:  Jamie L Fornsaglio; Travis J O'Brien; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

Review 6.  Metals and molecular carcinogenesis.

Authors:  Yusha Zhu; Max Costa
Journal:  Carcinogenesis       Date:  2020-09-24       Impact factor: 4.944

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.